Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Basilea Pharmaceutica (CH:BSLN)

:BSLN

BSLN

Basilea Pharmaceutica

RESEARCH TOOLSreports

Basilea Pharmaceutica (BSLN) Ratios

Compare

7 Followers

Basilea Pharmaceutica Ratios

CH:BSLN's free cash flow for Q4 2025 was CHF0.88. For the 2025 fiscal year, CH:BSLN's free cash flow was decreased by CHF and operating cash flow was CHF0.21. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	5.11	5.11	4.85	3.20	2.34
Quick Ratio	4.68	4.68	4.16	2.64	2.02
Cash Ratio	0.60	0.60	2.65	1.26	0.49
Solvency Ratio	0.21	0.26	0.45	0.07	0.06
Operating Cash Flow Ratio	1.03	1.26	1.63	0.30	0.09
Short-Term Operating Cash Flow Coverage	24.52	30.11	0.00	0.92	0.19
Net Current Asset Value	CHF 97.67M	CHF 97.67M	CHF 44.15M	CHF -31.15M	CHF -66.20M
Leverage Ratios
Debt-to-Assets Ratio	0.36	0.36	0.43	0.74	0.85
Debt-to-Equity Ratio	0.79	0.79	1.38	-12.86	-9.03
Debt-to-Capital Ratio	0.44	0.44	0.58	1.08	1.12
Long-Term Debt-to-Capital Ratio	0.41	0.41	0.54	1.12	1.19
Financial Leverage Ratio	2.20	2.20	3.18	-17.32	-10.66
Debt Service Coverage Ratio	9.10	22.31	18.52	0.87	0.55
Interest Coverage Ratio	20.57	0.00	14.08	1.71	1.88
Debt to Market Cap	0.14	0.13	0.19	0.26	0.31
Interest Debt Per Share	8.43	8.26	9.60	11.66	16.61
Net Debt to EBITDA	1.78	1.38	-0.14	2.96	5.74
Profitability Margins
Gross Profit Margin	74.32%	83.09%	81.45%	83.00%	81.86%
EBIT Margin	22.04%	22.20%	29.59%	13.74%	15.64%
EBITDA Margin	22.24%	22.20%	30.27%	14.71%	17.74%
Operating Profit Margin	21.94%	22.20%	29.34%	12.18%	12.55%
Pretax Profit Margin	20.08%	19.75%	28.90%	6.64%	8.19%
Net Profit Margin	17.90%	17.30%	37.21%	6.63%	8.22%
Continuous Operations Profit Margin	17.96%	17.34%	37.21%	6.63%	8.22%
Net Income Per EBT	89.16%	87.58%	128.76%	99.90%	100.37%
EBT Per EBIT	91.52%	88.95%	98.50%	54.47%	65.26%
Return on Assets (ROA)	11.45%	14.26%	30.10%	6.03%	5.50%
Return on Equity (ROE)	27.95%	31.42%	95.80%	-104.48%	-58.64%
Return on Capital Employed (ROCE)	17.00%	22.17%	28.83%	15.28%	12.70%
Return on Invested Capital (ROIC)	15.07%	19.29%	28.55%	13.40%	10.00%
Return on Tangible Assets	11.47%	14.27%	30.15%	6.05%	5.51%
Earnings Yield	5.15%	6.01%	15.52%	2.47%	2.24%
Efficiency Ratios
Receivables Turnover	2.85	3.67	3.69	5.65	2.39
Payables Turnover	3.08	2.61	3.37	4.58	140.33
Inventory Turnover	2.15	1.82	1.22	1.01	1.11
Fixed Asset Turnover	9.94	12.80	10.98	7.67	6.85
Asset Turnover	0.64	0.82	0.81	0.91	0.67
Working Capital Turnover Ratio	0.94	1.23	1.49	1.54	1.77
Cash Conversion Cycle	179.23	159.76	288.90	344.70	479.97
Days of Sales Outstanding	128.02	99.39	99.02	64.58	152.42
Days of Inventory Outstanding	169.83	200.22	298.27	359.77	330.15
Days of Payables Outstanding	118.63	139.85	108.39	79.65	2.60
Operating Cycle	297.85	299.61	397.29	424.35	482.57
Cash Flow Ratios
Operating Cash Flow Per Share	4.14	5.08	6.15	1.19	0.59
Free Cash Flow Per Share	3.94	4.87	6.01	1.10	0.32
CapEx Per Share	0.20	0.21	0.14	0.09	0.28
Free Cash Flow to Operating Cash Flow	0.95	0.96	0.98	0.93	0.53
Dividend Paid and CapEx Coverage Ratio	20.56	23.70	43.49	13.78	2.14
Capital Expenditure Coverage Ratio	20.56	23.70	43.49	13.78	2.14
Operating Cash Flow Coverage Ratio	0.50	0.62	0.67	0.11	0.04
Operating Cash Flow to Sales Ratio	0.28	0.27	0.36	0.09	0.05
Free Cash Flow Yield	7.63%	8.90%	14.53%	3.12%	0.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	19.69	16.63	6.44	40.50	44.72
Price-to-Sales (P/S) Ratio	3.54	2.88	2.40	2.69	3.68
Price-to-Book (P/B) Ratio	4.97	5.22	6.17	-42.32	-26.22
Price-to-Free Cash Flow (P/FCF) Ratio	13.29	11.24	6.88	32.04	144.75
Price-to-Operating Cash Flow Ratio	12.58	10.76	6.72	29.72	76.99
Price-to-Earnings Growth (PEG) Ratio	-0.43	-0.34	0.01	-2.75	-0.16
Price-to-Fair Value	4.97	5.22	6.17	-42.32	-26.22
Enterprise Value Multiple	17.71	14.33	7.78	21.22	26.47
Enterprise Value	702.05M	739.67M	490.88M	492.00M	693.80M
EV to EBITDA	17.50	14.33	7.78	21.22	26.47
EV to Sales	3.89	3.18	2.35	3.12	4.70
EV to Free Cash Flow	14.59	12.44	6.76	37.24	184.87
EV to Operating Cash Flow	13.89	11.91	6.60	34.54	98.33
Tangible Book Value Per Share	10.45	10.44	6.67	-0.88	-1.80
Shareholders’ Equity Per Share	10.48	10.47	6.70	-0.83	-1.75
Tax and Other Ratios
Effective Tax Rate	0.11	0.12	-0.29	<0.01	>-0.01
Revenue Per Share	14.78	19.02	17.25	13.15	12.46
Net Income Per Share	2.65	3.29	6.42	0.87	1.02
Tax Burden	0.89	0.88	1.29	1.00	1.00
Interest Burden	0.91	0.89	0.98	0.48	0.52
Research & Development to Revenue	0.48	0.46	0.37	0.49	0.50
SG&A to Revenue	0.00	0.00	0.15	0.21	0.21
Stock-Based Compensation to Revenue	<0.01	0.00	0.02	0.03	0.02
Income Quality	1.56	1.54	0.96	1.36	0.58

Currency in CHF